Becton Dickinson EPS - Earnings per Share 2010-2024 | BDX
Becton Dickinson annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Becton Dickinson EPS for the quarter ending September 30, 2024 was $1.45, a 314.29% increase year-over-year.
- Becton Dickinson EPS for the twelve months ending September 30, 2024 was $5.94, a 20.24% increase year-over-year.
- Becton Dickinson 2024 annual EPS was $5.93, a 20.04% increase from 2023.
- Becton Dickinson 2023 annual EPS was $4.94, a 15.99% decline from 2022.
- Becton Dickinson 2022 annual EPS was $5.88, a 14.16% decline from 2021.
| Becton Dickinson Annual EPS |
| 2024 |
$5.93 |
| 2023 |
$4.94 |
| 2022 |
$5.88 |
| 2021 |
$6.85 |
| 2020 |
$2.71 |
| 2019 |
$3.94 |
| 2018 |
$0.60 |
| 2017 |
$4.60 |
| 2016 |
$4.49 |
| 2015 |
$3.35 |
| 2014 |
$5.99 |
| 2013 |
$6.49 |
| 2012 |
$5.59 |
| 2011 |
$5.62 |
| 2010 |
$5.49 |
| 2009 |
$4.99 |
| Becton Dickinson Quarterly EPS |
| 2024-09-30 |
$1.45 |
| 2024-06-30 |
$1.68 |
| 2024-03-31 |
$1.85 |
| 2023-12-31 |
$0.96 |
| 2023-09-30 |
$0.35 |
| 2023-06-30 |
$1.36 |
| 2023-03-31 |
$1.53 |
| 2022-12-31 |
$1.70 |
| 2022-09-30 |
$0.92 |
| 2022-06-30 |
$1.18 |
| 2022-03-31 |
$1.50 |
| 2021-12-31 |
$2.28 |
| 2021-09-30 |
$0.84 |
| 2021-06-30 |
$1.72 |
| 2021-03-31 |
$0.94 |
| 2020-12-31 |
$3.35 |
| 2020-09-30 |
$0.34 |
| 2020-06-30 |
$0.97 |
| 2020-03-31 |
$0.53 |
| 2019-12-31 |
$0.87 |
| 2019-09-30 |
$0.45 |
| 2019-06-30 |
$1.51 |
| 2019-03-31 |
$-0.07 |
| 2018-12-31 |
$2.05 |
| 2018-09-30 |
$-0.48 |
| 2018-06-30 |
$2.03 |
| 2018-03-31 |
$-0.19 |
| 2017-12-31 |
$-0.76 |
| 2017-09-30 |
$1.19 |
| 2017-06-30 |
$-0.75 |
| 2017-03-31 |
$1.58 |
| 2016-12-31 |
$2.58 |
| 2016-09-30 |
$0.07 |
| 2016-06-30 |
$1.80 |
| 2016-03-31 |
$1.56 |
| 2015-12-31 |
$1.06 |
| 2015-09-30 |
$0.78 |
| 2015-06-30 |
$0.29 |
| 2015-03-31 |
$1.08 |
| 2014-12-31 |
$1.20 |
| 2014-09-30 |
$1.52 |
| 2014-06-30 |
$1.65 |
| 2014-03-31 |
$1.45 |
| 2013-12-31 |
$1.37 |
| 2013-09-30 |
$0.45 |
| 2013-06-30 |
$1.52 |
| 2013-03-31 |
$1.39 |
| 2012-12-31 |
$3.13 |
| 2012-09-30 |
$1.40 |
| 2012-06-30 |
$1.59 |
| 2012-03-31 |
$1.39 |
| 2011-12-31 |
$1.21 |
| 2011-09-30 |
$1.35 |
| 2011-06-30 |
$1.53 |
| 2011-03-31 |
$1.38 |
| 2010-12-31 |
$1.36 |
| 2010-09-30 |
$1.66 |
| 2010-06-30 |
$1.29 |
| 2010-03-31 |
$1.24 |
| 2009-12-31 |
$1.30 |
| 2009-09-30 |
$1.28 |
| 2009-06-30 |
$1.39 |
| 2009-03-31 |
$1.06 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$69.388B |
$19.372B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
